Global PCR-based Enteric Disease Testing Market Research Report 2023

PCR-based Enteric Disease Testing Market

The global PCR-based Enteric Disease Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for PCR-based Enteric Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for PCR-based Enteric Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for PCR-based Enteric Disease Testing in Clostridium Difficile is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of PCR-based Enteric Disease Testing include Thermo Fisher Scientific, Vela Diagnostics, CorisBioconcept, Meridian Life Science, Bio-Rad Laboratories, Abbott (ALERE), bioMerieux SA, Trinity Biotech and DiaSorin Molecular, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PCR-based Enteric Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCR-based Enteric Disease Testing.

The PCR-based Enteric Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PCR-based Enteric Disease Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PCR-based Enteric Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of PCR-based Enteric Disease Testing Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Analyzers/Instruments

1.2.3 Kits/Panels

1.3 Market by Application

1.3.1 Global PCR-based Enteric Disease Testing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clostridium Difficile

1.3.3 Campylobacteriosis

1.3.4 Cholera

1.3.5 E. coli Infection

1.3.6 H. pylori Infection

1.3.7 Salmonellosis

1.3.8 Shigellosis

1.3.9 Rotavirus Infection

1.3.10 Norovirus Infection

1.3.11 Parasitic Enteric Disease

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global PCR-based Enteric Disease Testing Market Perspective (2018-2029)

2.2 PCR-based Enteric Disease Testing Growth Trends by Region

2.2.1 Global PCR-based Enteric Disease Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 PCR-based Enteric Disease Testing Historic Market Size by Region (2018-2023)

2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Region (2024-2029)

2.3 PCR-based Enteric Disease Testing Market Dynamics

2.3.1 PCR-based Enteric Disease Testing Industry Trends

2.3.2 PCR-based Enteric Disease Testing Market Drivers

2.3.3 PCR-based Enteric Disease Testing Market Challenges

2.3.4 PCR-based Enteric Disease Testing Market Restraints

3.1 Global Top PCR-based Enteric Disease Testing Players by Revenue

3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2018-2023)

3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2018-2023)

3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue

3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio

3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2022

3.5 PCR-based Enteric Disease Testing Key Players Head office and Area Served

3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service

3.7 Date of Enter into PCR-based Enteric Disease Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2018-2023)

4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2024-2029)

5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2018-2023)

5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2024-2029)

6.1 North America PCR-based Enteric Disease Testing Market Size (2018-2029)

6.2 North America PCR-based Enteric Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America PCR-based Enteric Disease Testing Market Size by Country (2018-2023)

6.4 North America PCR-based Enteric Disease Testing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe PCR-based Enteric Disease Testing Market Size (2018-2029)

7.2 Europe PCR-based Enteric Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe PCR-based Enteric Disease Testing Market Size by Country (2018-2023)

7.4 Europe PCR-based Enteric Disease Testing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size (2018-2029)

8.2 Asia-Pacific PCR-based Enteric Disease Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2018-2023)

8.4 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America PCR-based Enteric Disease Testing Market Size (2018-2029)

9.2 Latin America PCR-based Enteric Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America PCR-based Enteric Disease Testing Market Size by Country (2018-2023)

9.4 Latin America PCR-based Enteric Disease Testing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size (2018-2029)

10.2 Middle East & Africa PCR-based Enteric Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2018-2023)

10.4 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction

11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Vela Diagnostics

11.2.1 Vela Diagnostics Company Detail

11.2.2 Vela Diagnostics Business Overview

11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction

11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.2.5 Vela Diagnostics Recent Development

11.3 CorisBioconcept

11.3.1 CorisBioconcept Company Detail

11.3.2 CorisBioconcept Business Overview

11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction

11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.3.5 CorisBioconcept Recent Development

11.4 Meridian Life Science

11.4.1 Meridian Life Science Company Detail

11.4.2 Meridian Life Science Business Overview

11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction

11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.4.5 Meridian Life Science Recent Development

11.5 Bio-Rad Laboratories

11.5.1 Bio-Rad Laboratories Company Detail

11.5.2 Bio-Rad Laboratories Business Overview

11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction

11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.5.5 Bio-Rad Laboratories Recent Development

11.6 Abbott (ALERE)

11.6.1 Abbott (ALERE) Company Detail

11.6.2 Abbott (ALERE) Business Overview

11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction

11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.6.5 Abbott (ALERE) Recent Development

11.7 bioMerieux SA

11.7.1 bioMerieux SA Company Detail

11.7.2 bioMerieux SA Business Overview

11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction

11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.7.5 bioMerieux SA Recent Development

11.8 Trinity Biotech

11.8.1 Trinity Biotech Company Detail

11.8.2 Trinity Biotech Business Overview

11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction

11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.8.5 Trinity Biotech Recent Development

11.9 DiaSorin Molecular

11.9.1 DiaSorin Molecular Company Detail

11.9.2 DiaSorin Molecular Business Overview

11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction

11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.9.5 DiaSorin Molecular Recent Development

11.10 Etta Healthcare (Ovagene Oncology)

11.10.1 Etta Healthcare (Ovagene Oncology) Company Detail

11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview

11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction

11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.10.5 Etta Healthcare (Ovagene Oncology) Recent Development

11.11 ExcitePCR (PositiveID Corporation)

11.11.1 ExcitePCR (PositiveID Corporation) Company Detail

11.11.2 ExcitePCR (PositiveID Corporation) Business Overview

11.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction

11.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.11.5 ExcitePCR (PositiveID Corporation) Recent Development

11.12 Flow Alliance

11.12.1 Flow Alliance Company Detail

11.12.2 Flow Alliance Business Overview

11.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction

11.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.12.5 Flow Alliance Recent Development

11.13 Fluid-Screen

11.13.1 Fluid-Screen Company Detail

11.13.2 Fluid-Screen Business Overview

11.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction

11.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.13.5 Fluid-Screen Recent Development

11.14 FluimediX

11.14.1 FluimediX Company Detail

11.14.2 FluimediX Business Overview

11.14.3 FluimediX PCR-based Enteric Disease Testing Introduction

11.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.14.5 FluimediX Recent Development

11.15 Fluxergy

11.15.1 Fluxergy Company Detail

11.15.2 Fluxergy Business Overview

11.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction

11.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.15.5 Fluxergy Recent Development

11.16 Focus Diagnostics (DiaSorin Molecular)

11.16.1 Focus Diagnostics (DiaSorin Molecular) Company Detail

11.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview

11.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction

11.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development

11.17 Future Horizon Scientific

11.17.1 Future Horizon Scientific Company Detail

11.17.2 Future Horizon Scientific Business Overview

11.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction

11.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.17.5 Future Horizon Scientific Recent Development

11.18 Genalyte

11.18.1 Genalyte Company Detail

11.18.2 Genalyte Business Overview

11.18.3 Genalyte PCR-based Enteric Disease Testing Introduction

11.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.18.5 Genalyte Recent Development

11.19 GeneFluidics

11.19.1 GeneFluidics Company Detail

11.19.2 GeneFluidics Business Overview

11.19.3 GeneFluidics PCR-based Enteric Disease Testing Introduction

11.19.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.19.5 GeneFluidics Recent Development

11.20 GenSpeed Biotech

11.20.1 GenSpeed Biotech Company Detail

11.20.2 GenSpeed Biotech Business Overview

11.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction

11.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.20.5 GenSpeed Biotech Recent Development

11.21 Gulf Bio Analytical

11.21.1 Gulf Bio Analytical Company Detail

11.21.2 Gulf Bio Analytical Business Overview

11.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction

11.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.21.5 Gulf Bio Analytical Recent Development

11.22 Hahn-Schickard

11.22.1 Hahn-Schickard Company Detail

11.22.2 Hahn-Schickard Business Overview

11.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction

11.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.22.5 Hahn-Schickard Recent Development

11.23 Helvoet

11.23.1 Helvoet Company Detail

11.23.2 Helvoet Business Overview

11.23.3 Helvoet PCR-based Enteric Disease Testing Introduction

11.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.23.5 Helvoet Recent Development

11.24 HemoCue

11.24.1 HemoCue Company Detail

11.24.2 HemoCue Business Overview

11.24.3 HemoCue PCR-based Enteric Disease Testing Introduction

11.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.24.5 HemoCue Recent Development

11.25 Danaher

11.25.1 Danaher Company Detail

11.25.2 Danaher Business Overview

11.25.3 Danaher PCR-based Enteric Disease Testing Introduction

11.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.25.5 Danaher Recent Development

11.26 IDEX Health&Science

11.26.1 IDEX Health&Science Company Detail

11.26.2 IDEX Health&Science Business Overview

11.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction

11.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.26.5 IDEX Health&Science Recent Development

11.27 iLine Microsystems

11.27.1 iLine Microsystems Company Detail

11.27.2 iLine Microsystems Business Overview

11.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction

11.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.27.5 iLine Microsystems Recent Development

11.28 Inflammatix

11.28.1 Inflammatix Company Detail

11.28.2 Inflammatix Business Overview

11.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction

11.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2018-2023)

11.28.5 Inflammatix Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Analyzers/Instruments

    Table 3. Key Players of Kits/Panels

    Table 4. Global PCR-based Enteric Disease Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global PCR-based Enteric Disease Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global PCR-based Enteric Disease Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global PCR-based Enteric Disease Testing Market Share by Region (2018-2023)

    Table 8. Global PCR-based Enteric Disease Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global PCR-based Enteric Disease Testing Market Share by Region (2024-2029)

    Table 10. PCR-based Enteric Disease Testing Market Trends

    Table 11. PCR-based Enteric Disease Testing Market Drivers

    Table 12. PCR-based Enteric Disease Testing Market Challenges

    Table 13. PCR-based Enteric Disease Testing Market Restraints

    Table 14. Global PCR-based Enteric Disease Testing Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global PCR-based Enteric Disease Testing Market Share by Players (2018-2023)

    Table 16. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2022)

    Table 17. Ranking of Global Top PCR-based Enteric Disease Testing Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by PCR-based Enteric Disease Testing Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service

    Table 21. Date of Enter into PCR-based Enteric Disease Testing Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global PCR-based Enteric Disease Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2018-2023)

    Table 25. Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2024-2029)

    Table 27. Global PCR-based Enteric Disease Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2018-2023)

    Table 29. Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2024-2029)

    Table 31. North America PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America PCR-based Enteric Disease Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America PCR-based Enteric Disease Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe PCR-based Enteric Disease Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe PCR-based Enteric Disease Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific PCR-based Enteric Disease Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America PCR-based Enteric Disease Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America PCR-based Enteric Disease Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Thermo Fisher Scientific Company Detail

    Table 47. Thermo Fisher Scientific Business Overview

    Table 48. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product

    Table 49. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 50. Thermo Fisher Scientific Recent Development

    Table 51. Vela Diagnostics Company Detail

    Table 52. Vela Diagnostics Business Overview

    Table 53. Vela Diagnostics PCR-based Enteric Disease Testing Product

    Table 54. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 55. Vela Diagnostics Recent Development

    Table 56. CorisBioconcept Company Detail

    Table 57. CorisBioconcept Business Overview

    Table 58. CorisBioconcept PCR-based Enteric Disease Testing Product

    Table 59. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 60. CorisBioconcept Recent Development

    Table 61. Meridian Life Science Company Detail

    Table 62. Meridian Life Science Business Overview

    Table 63. Meridian Life Science PCR-based Enteric Disease Testing Product

    Table 64. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 65. Meridian Life Science Recent Development

    Table 66. Bio-Rad Laboratories Company Detail

    Table 67. Bio-Rad Laboratories Business Overview

    Table 68. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product

    Table 69. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 70. Bio-Rad Laboratories Recent Development

    Table 71. Abbott (ALERE) Company Detail

    Table 72. Abbott (ALERE) Business Overview

    Table 73. Abbott (ALERE) PCR-based Enteric Disease Testing Product

    Table 74. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 75. Abbott (ALERE) Recent Development

    Table 76. bioMerieux SA Company Detail

    Table 77. bioMerieux SA Business Overview

    Table 78. bioMerieux SA PCR-based Enteric Disease Testing Product

    Table 79. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 80. bioMerieux SA Recent Development

    Table 81. Trinity Biotech Company Detail

    Table 82. Trinity Biotech Business Overview

    Table 83. Trinity Biotech PCR-based Enteric Disease Testing Product

    Table 84. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 85. Trinity Biotech Recent Development

    Table 86. DiaSorin Molecular Company Detail

    Table 87. DiaSorin Molecular Business Overview

    Table 88. DiaSorin Molecular PCR-based Enteric Disease Testing Product

    Table 89. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 90. DiaSorin Molecular Recent Development

    Table 91. Etta Healthcare (Ovagene Oncology) Company Detail

    Table 92. Etta Healthcare (Ovagene Oncology) Business Overview

    Table 93. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product

    Table 94. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 95. Etta Healthcare (Ovagene Oncology) Recent Development

    Table 96. ExcitePCR (PositiveID Corporation) Company Detail

    Table 97. ExcitePCR (PositiveID Corporation) Business Overview

    Table 98. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product

    Table 99. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 100. ExcitePCR (PositiveID Corporation) Recent Development

    Table 101. Flow Alliance Company Detail

    Table 102. Flow Alliance Business Overview

    Table 103. Flow Alliance PCR-based Enteric Disease Testing Product

    Table 104. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 105. Flow Alliance Recent Development

    Table 106. Fluid-Screen Company Detail

    Table 107. Fluid-Screen Business Overview

    Table 108. Fluid-Screen PCR-based Enteric Disease Testing Product

    Table 109. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 110. Fluid-Screen Recent Development

    Table 111. FluimediX Company Detail

    Table 112. FluimediX Business Overview

    Table 113. FluimediX PCR-based Enteric Disease Testing Product

    Table 114. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 115. FluimediX Recent Development

    Table 116. Fluxergy Company Detail

    Table 117. Fluxergy Business Overview

    Table 118. Fluxergy PCR-based Enteric Disease Testing Product

    Table 119. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 120. Fluxergy Recent Development

    Table 121. Focus Diagnostics (DiaSorin Molecular) Company Detail

    Table 122. Focus Diagnostics (DiaSorin Molecular) Business Overview

    Table 123. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product

    Table 124. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 125. Focus Diagnostics (DiaSorin Molecular) Recent Development

    Table 126. Future Horizon Scientific Company Detail

    Table 127. Future Horizon Scientific Business Overview

    Table 128. Future Horizon Scientific PCR-based Enteric Disease Testing Product

    Table 129. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 130. Future Horizon Scientific Recent Development

    Table 131. Genalyte Company Detail

    Table 132. Genalyte Business Overview

    Table 133. Genalyte PCR-based Enteric Disease Testing Product

    Table 134. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 135. Genalyte Recent Development

    Table 136. GeneFluidics Company Detail

    Table 137. GeneFluidics Business Overview

    Table 138. GeneFluidics PCR-based Enteric Disease Testing Product

    Table 139. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 140. GeneFluidics Recent Development

    Table 141. GenSpeed Biotech Company Detail

    Table 142. GenSpeed Biotech Business Overview

    Table 143. GenSpeed Biotech PCR-based Enteric Disease Testing Product

    Table 144. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 145. GenSpeed Biotech Recent Development

    Table 146. Gulf Bio Analytical Company Detail

    Table 147. Gulf Bio Analytical Business Overview

    Table 148. Gulf Bio Analytical PCR-based Enteric Disease Testing Product

    Table 149. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 150. Gulf Bio Analytical Recent Development

    Table 151. Hahn-Schickard Company Detail

    Table 152. Hahn-Schickard Business Overview

    Table 153. Hahn-Schickard PCR-based Enteric Disease Testing Product

    Table 154. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 155. Hahn-Schickard Recent Development

    Table 156. Helvoet Company Detail

    Table 157. Helvoet Business Overview

    Table 158. Helvoet PCR-based Enteric Disease Testing Product

    Table 159. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 160. Helvoet Recent Development

    Table 161. HemoCue Company Detail

    Table 162. HemoCue Business Overview

    Table 163. HemoCue PCR-based Enteric Disease Testing Product

    Table 164. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 165. HemoCue Recent Development

    Table 166. Danaher Company Detail

    Table 167. Danaher Business Overview

    Table 168. Danaher PCR-based Enteric Disease Testing Product

    Table 169. Danaher Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 170. Danaher Recent Development

    Table 171. IDEX Health&Science Company Detail

    Table 172. IDEX Health&Science Business Overview

    Table 173. IDEX Health&Science PCR-based Enteric Disease Testing Product

    Table 174. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 175. IDEX Health&Science Recent Development

    Table 176. iLine Microsystems Company Detail

    Table 177. iLine Microsystems Business Overview

    Table 178. iLine Microsystems PCR-based Enteric Disease Testing Product

    Table 179. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 180. iLine Microsystems Recent Development

    Table 181. Inflammatix Company Detail

    Table 182. Inflammatix Business Overview

    Table 183. Inflammatix PCR-based Enteric Disease Testing Product

    Table 184. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2018-2023) & (US$ Million)

    Table 185. Inflammatix Recent Development

    Table 186. Research Programs/Design for This Report

    Table 187. Key Data Information from Secondary Sources

    Table 188. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global PCR-based Enteric Disease Testing Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global PCR-based Enteric Disease Testing Market Share by Type: 2022 VS 2029

    Figure 3. Analyzers/Instruments Features

    Figure 4. Kits/Panels Features

    Figure 5. Global PCR-based Enteric Disease Testing Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global PCR-based Enteric Disease Testing Market Share by Application: 2022 VS 2029

    Figure 7. Clostridium Difficile Case Studies

    Figure 8. Campylobacteriosis Case Studies

    Figure 9. Cholera Case Studies

    Figure 10. E. coli Infection Case Studies

    Figure 11. H. pylori Infection Case Studies

    Figure 12. Salmonellosis Case Studies

    Figure 13. Shigellosis Case Studies

    Figure 14. Rotavirus Infection Case Studies

    Figure 15. Norovirus Infection Case Studies

    Figure 16. Parasitic Enteric Disease Case Studies

    Figure 17. PCR-based Enteric Disease Testing Report Years Considered

    Figure 18. Global PCR-based Enteric Disease Testing Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 19. Global PCR-based Enteric Disease Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 20. Global PCR-based Enteric Disease Testing Market Share by Region: 2022 VS 2029

    Figure 21. Global PCR-based Enteric Disease Testing Market Share by Players in 2022

    Figure 22. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2022)

    Figure 23. The Top 10 and 5 Players Market Share by PCR-based Enteric Disease Testing Revenue in 2022

    Figure 24. North America PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. North America PCR-based Enteric Disease Testing Market Share by Country (2018-2029)

    Figure 26. United States PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Canada PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Europe PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Europe PCR-based Enteric Disease Testing Market Share by Country (2018-2029)

    Figure 30. Germany PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. France PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. U.K. PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Italy PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Russia PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Nordic Countries PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Region (2018-2029)

    Figure 38. China PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Japan PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. South Korea PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Southeast Asia PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. India PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Australia PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Latin America PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Latin America PCR-based Enteric Disease Testing Market Share by Country (2018-2029)

    Figure 46. Mexico PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Brazil PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Country (2018-2029)

    Figure 50. Turkey PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia PCR-based Enteric Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 53. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 54. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 55. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 56. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 57. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 58. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 59. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 60. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 61. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 62. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 63. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 64. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 65. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 66. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 67. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 68. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 69. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 70. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 71. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 72. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 73. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 74. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 75. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 76. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 77. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 78. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 79. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2018-2023)

    Figure 80. Bottom-up and Top-down Approaches for This Report

    Figure 81. Data Triangulation

    Figure 82. Key Executives Interviewed